Search results

  1. Epilepsy

    Everything NICE has said on diagnosing and managing the epilepsies in adults and children in primary and secondary care in an interactive flowchart

  2. Headaches in over 12s: diagnosis and management (CG150)

    This guideline covers advice on the diagnosis and management of tension-type headache, migraine (including migraine with aura and menstrual-related migraine), cluster headache and medication overuse headache in young people (aged 12 years and older) and adults. It aims to improve the recognition and management of headaches, with more targeted treatment to improve the quality of life for people with headaches, and to reduce unnecessary investigations.

  3. Headaches

    Everything NICE has said on the most common primary headache disorders in young people aged 12 years and older and adults in an interactive flowchart

  4. Epilepsies: diagnosis and management (CG137)

    The guideline covers diagnosing, treating and managing epilepsy and seizures in children, young people and adults in primary and secondary care. It offers best practice advice on managing epilepsy to improve health outcomes so that people with epilepsy can fully participate in daily life.

  5. Andexanet alfa for reversing anticoagulation from apixaban or rivaroxaban (TA697)

    Evidence-based recommendations on andexanet alfa (Ondexxya) for reversing anticoagulation form apixaban or rivaroxaban in adults with life-threatening or uncont

  6. Acute upper gastrointestinal bleeding

    Everything NICE has said on risk assessment and management of acute upper gastrointestinal bleeding in people 16 years and older in an interactive flowchart

  7. Stroke

    Everything NICE has said on preventing, diagnosing and managing stroke and transient ischaemic attack (TIA) in people over 16 in an interactive flowchart

  8. Neuropathic pain

    Everything NICE has said on pharmacological management of neuropathic pain in adults in non-specialist settings in an interactive flowchart

  9. Depression

    Everything NICE has said on identifying, treating and managing depression in children, young people and adults in an interactive flowchart

  10. Pneumonia

    Everything NICE has said on assessing and managing community- and hospital-acquired pneumonia in an interactive flowchart

  11. Alcohol-use disorders

    Everything NICE has said on preventing, diagnosing and managing alcohol-related disorders in an interactive flowchart

  12. Trauma

    Everything NICE has said on assessing and managing trauma in an interactive flowchart

  13. Head injury

    Everything NICE has said on triage, assessment, investigation and management of head injury in infants, children and adults in an interactive flowchart

  14. Induction of labour

    Everything NICE has said on inducing labour in an interactive flowchart

  15. Chronic heart failure

    Everything NICE has said on diagnosing and managing chronic heart failure in adults in an interactive flowchart

  16. Venous thromboembolism

    Everything NICE has said on assessing, diagnosing, treating and reducing the risk of venous thromboembolism in adults in an interactive flowchart

  17. Lung cancer

    Everything NICE has said on diagnosing and treating lung cancer in an interactive flowchart

  18. Blood and bone marrow cancers

    Everything NICE has said on blood and bone marrow cancers including leukaemia in an interactive flowchart

  19. The percentage of patients with atrial fibrillation in whom stroke risk has been assessed using the CHA2DS2-VASc score risk stratification scoring system in the preceding 12 months (excluding those patients with a previous CHADS2 or CHA2DS2-VASc score of 2 or more)

    The percentage of patients with atrial fibrillation in whom stroke risk has been assessed using the CHA2DS2-VASc score risk stratification scoring...

  20. Familial hypercholesterolaemia

    Everything NICE has said on familial hypercholesterolaemia in an interactive flowchart

  21. Ovarian cancer

    Everything NICE has said on recognising and managing ovarian cancer in an interactive flowchart

  22. Cardiovascular disease prevention

    Everything NICE has said on cardiovascular risk assessment and modifying blood lipids for preventing cardiovascular disease in adults

  23. Bladder cancer

    Everything NICE has said on bladder cancer in adults in an interactive flowchart

  24. Glaucoma

    Everything NICE has said on assessing, treating and managing glaucoma in adults in an interactive flowchart

  25. Myeloma

    Everything NICE has said on diagnosing and managing myeloma, and preventing and managing its complications in an interactive flowchart

  26. Bempedoic acid with ezetimibe for treating primary hypercholesterolaemia or mixed dyslipidaemia (TA694)

    Evidence-based recommendations on bempedoic acid with ezetimibe (Nilemdo and Nustendi) for treating primary hypercholesterolaemia or mixed dyslipidaemia as an

  27. Carfilzomib with dexamethasone and lenalidomide for previously treated multiple myeloma (TA695)

    Evidence-based recommendations on carfilzomib (Kyprolis) with dexamethasone and lenalidomide (Revlimid) for previously treated multiple myeloma in adults

  28. Pembrolizumab for treating locally advanced or metastatic urothelial carcinoma after platinum-containing chemotherapy (TA692)

    Evidence-based recommendations on pembrolizumab (Keytruda) for treating locally advanced or metastatic urothelial carcinoma after platinum

  29. Olaparib plus bevacizumab for maintenance treatment of advanced ovarian, fallopian tube or primary peritoneal cancer (TA693)

    Evidence-based recommendations on olaparib (Lynparza) plus bevacizumab (Avastin) for maintenance treatment of advanced ovarian, fallopian tube or primary perito

  30. Deep brain stimulation for chronic, severe, treatment-resistant obsessive-compulsive disorder in adults (IPG693)

    Evidence-based recommendations on deep brain stimulation for chronic, severe, treatment-resistant obsessive-compulsive disorder in adults. This involves implant

  31. The percentage of patients with atrial fibrillation, currently treated with an anticoagulant, who have had a review in the preceding 12 months which included: assessment of stroke/VTE risk; assessment of bleeding risk; assessment of renal function, creatinine clearance, FBC and LFTs as appropriate for their anticoagulation therapy; any adverse effects related to anticoagulation; assessment of compliance; choice of anticoagulant

    The percentage of patients with atrial fibrillation, currently treated with an anticoagulant, who have had a review in the preceding 12 months which...

  32. The percentage of patients with one or more of the following conditions: CHD, atrial fibrillation, chronic heart failure, stroke or TIA, diabetes or dementia with a FAST score of 3 or more or AUDIT-C score of 5 or more in the preceding 2 years who have received brief intervention to help them reduce their alcohol related risk within 3 months of the score being recorded

    The percentage of patients with one or more of the following conditions: CHD, atrial fibrillation, chronic heart failure, stroke or TIA, diabetes or...

  33. Atrial fibrillation

    Everything NICE has said on diagnosing and managing atrial fibrillation in an interactive flowchart

  34. Atrial fibrillation: diagnosis and management (NG196)

    This guideline covers diagnosing and managing atrial fibrillation in adults. It includes guidance on providing the best care and treatment for people with atrial fibrillation, including assessing and managing risks of stroke and bleeding.

  35. Gastrointestinal conditions

    Everything NICE has said on gastrointestinal conditions in an interactive flowchart